Bausch Health Companies Inc. (BHC) FY2026 Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
Bausch Health Companies Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net (loss) income → Net cash from operating activities: $260,000,000.00Depreciation and amortization of intangible assets → Operating adjustments reconciliation: $281,000,000.00Accounts payable, accrued and other liabilities → Operating adjustments reconciliation: $73,000,000.00Share-based compensation → Operating adjustments reconciliation: $54,000,000.00Prepaid expenses and other current assets → Operating adjustments reconciliation: $36,000,000.00Amortization and write-off of debt premiums, discounts and issuance costs → Operating adjustments reconciliation: $21,000,000.00Allowances for losses on trade receivable and inventories → Operating adjustments reconciliation: $19,000,000.00Deferred income taxes → Operating adjustments reconciliation: $17,000,000.00Asset impairments → Operating adjustments reconciliation: $9,000,000.00Acquisition-related contingent consideration → Operating adjustments reconciliation: $6,000,000.00Adjustments to accrued legal settlements → Operating adjustments reconciliation: $6,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $410,000,000.00Operating adjustments reconciliation → Trade receivables: $70,000,000.00Operating adjustments reconciliation → Inventories: $22,000,000.00Operating adjustments reconciliation → Payments of accrued legal settlements: $16,000,000.00Operating adjustments reconciliation → Payments of contingent consideration adjustments, including accretion: $2,000,000.00Operating adjustments reconciliation → Gain excluded from hedge effectiveness: $1,000,000.00Operating adjustments reconciliation → Foreign exchange and other: $1,000,000.00Proceeds from sale of marketable securities → investing reconciliation: $4,000,000.00investing reconciliation → Purchases of property, plant and equipment: $77,000,000.00investing reconciliation → Acquisitions and other investments: $15,000,000.00investing reconciliation → Purchases of marketable securities: $5,000,000.00Net cash used in financing activities → financing reconciliation: $49,000,000.00Issuance of long-term debt, net of discounts → financing reconciliation: $84,000,000.00financing reconciliation → Repayments of long-term debt and other financial liabilities: $112,000,000.00financing reconciliation → Payments of employee withholding taxes related to share-based awards: $8,000,000.00financing reconciliation → Other: $7,000,000.00financing reconciliation → Payments of acquisition-related contingent consideration: $6,000,000.00Net cash used in investing activities → investing reconciliation: $93,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $1,312,000,000.00Net cash from operating activities → Cash sources and uses: $670,000,000.00Cash sources and uses → Exchange-rate effect: $2,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $1,838,000,000.00Cash sources and uses → Net cash used in investing activities: $93,000,000.00Cash sources and uses → Net cash used in financing activities: $49,000,000.00Net (loss) income: $260,000,000.00Net (loss) income+$260.00 MDepreciation and amortization of intangible assets: $281,000,000.00Depreciation & amortization+$281.00 MAmortization and write-off of debt premiums, discounts and issuance costs: $21,000,000.00Debt cost amortization+$21.00 MGoodwill impairments: $0.00Acquisition-related contingent consideration: $6,000,000.00Acquisition-related consideration+$6.00 MAllowances for losses on trade receivable and inventories: $19,000,000.00Receivable & inventory allowance+$19.00 MDeferred income taxes: $17,000,000.00Deferred income taxes+$17.00 MNet gain on sale of assets: $0.00Adjustments to accrued legal settlements: $6,000,000.00Legal settlement accruals+$6.00 MPayments of accrued legal settlements: -$16,000,000.00Legal settlements paid−$16.00 MShare-based compensation: $54,000,000.00Stock-based compensation+$54.00 MGain excluded from hedge effectiveness: -$1,000,000.00Hedge-excluded gain−$1.00 MLoss (gain) on extinguishment of debt: $0.00Payments of contingent consideration adjustments, including accretion: -$2,000,000.00Contingent consideration paid−$2.00 MAmortization of inventory step-up resulting from acquisitions: $0.00Foreign exchange and other: -$1,000,000.00Foreign exchange and other−$1.00 MTrade receivables: -$70,000,000.00Accounts receivable−$70.00 MInventories: -$22,000,000.00Inventories−$22.00 MPrepaid expenses and other current assets: $36,000,000.00Prepaid & other assets+$36.00 MAccounts payable, accrued and other liabilities: $73,000,000.00Payables & accrued liabilities+$73.00 MAsset impairments: $9,000,000.00Asset impairments+$9.00 MNet cash from operating activities: $670,000,000.00Operating cash+$670.00 MOperating adjustments reconciliation: $522,000,000.00Issuance of long-term debt, net of discounts: $84,000,000.00Long-term debt issued+$84.00 MRepayments of long-term debt and other financial liabilities: -$112,000,000.00Long-term debt repaid−$112.00 MPayments of employee withholding taxes related to share-based awards: -$8,000,000.00Stock-award tax withholding−$8.00 MPayments of acquisition-related contingent consideration: -$6,000,000.00Contingent consideration paid−$6.00 MPayments of financing costs: $0.00Other: -$7,000,000.00Other financing, net−$7.00 MNet cash used in financing activities: -$49,000,000.00. Cash required to fund net payments.Financing cash−$49.00 Mfinancing reconciliation: $133,000,000.00Acquisitions and other investments: -$15,000,000.00Acquisitions & other investments−$15.00 MPurchases of property, plant and equipment: -$77,000,000.00PP&E purchases−$77.00 MAcquisition of intangible assets and other assets: $0.00Purchases of marketable securities: -$5,000,000.00Marketable securities purchases−$5.00 MProceeds from sale of marketable securities: $4,000,000.00Marketable securities proceeds+$4.00 MProceeds from sale of assets and businesses, net of costs to sell: $0.00Interest settlements from cross-currency swaps: $0.00Net cash used in investing activities: -$93,000,000.00. Cash required to fund net payments.Investing cash−$93.00 Minvesting reconciliation: $97,000,000.00Cash sources and uses: $1,982,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $1,312,000,000.00Beginning cash$1.31 BEnding cash: Cash, cash equivalents, and restricted cash: $1,838,000,000.00Ending cash$1.84 BExchange-rate effect: -$2,000,000.00FX effect−$2.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$593.00 MOperating cash − cash spent on PP&ECash flow / Net income2.58×Operating cash flow ÷ net incomeNet cash change+$526.00 MEnding cash − beginning cash
Chart details

Bausch Health Companies Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
1,312,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
670,000,000 US dollars. Net cash provided.
Net (loss) income
260,000,000 US dollars
Depreciation and amortization of intangible assets
281,000,000 US dollars
Amortization and write-off of debt premiums, discounts and issuance costs
21,000,000 US dollars
Goodwill impairments
0 US dollars
Acquisition-related contingent consideration
6,000,000 US dollars
Allowances for losses on trade receivable and inventories
19,000,000 US dollars
Deferred income taxes
17,000,000 US dollars
Net gain on sale of assets
0 US dollars
Adjustments to accrued legal settlements
6,000,000 US dollars
Payments of accrued legal settlements
negative 16,000,000 US dollars
Share-based compensation
54,000,000 US dollars
Gain excluded from hedge effectiveness
negative 1,000,000 US dollars
Loss (gain) on extinguishment of debt
0 US dollars
Payments of contingent consideration adjustments, including accretion
negative 2,000,000 US dollars
Amortization of inventory step-up resulting from acquisitions
0 US dollars
Foreign exchange and other
negative 1,000,000 US dollars
Trade receivables
negative 70,000,000 US dollars
Inventories
negative 22,000,000 US dollars
Prepaid expenses and other current assets
36,000,000 US dollars
Accounts payable, accrued and other liabilities
73,000,000 US dollars
Asset impairments
9,000,000 US dollars
Investing activities
negative 93,000,000 US dollars. Net cash used.
Acquisitions and other investments
negative 15,000,000 US dollars
Purchases of property, plant and equipment
negative 77,000,000 US dollars
Acquisition of intangible assets and other assets
0 US dollars
Purchases of marketable securities
negative 5,000,000 US dollars
Proceeds from sale of marketable securities
4,000,000 US dollars
Proceeds from sale of assets and businesses, net of costs to sell
0 US dollars
Interest settlements from cross-currency swaps
0 US dollars
Financing activities
negative 49,000,000 US dollars. Net cash used.
Issuance of long-term debt, net of discounts
84,000,000 US dollars
Repayments of long-term debt and other financial liabilities
negative 112,000,000 US dollars
Payments of employee withholding taxes related to share-based awards
negative 8,000,000 US dollars
Payments of acquisition-related contingent consideration
negative 6,000,000 US dollars
Payments of financing costs
0 US dollars
Other
negative 7,000,000 US dollars
Operating adjustment reconciliation
522,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
133,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
97,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 2,000,000 US dollars
Ending cash on Jun 30, 2026
1,838,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
1,982,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
526,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
2.58×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
670,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
77,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
593,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $410.00M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 670,000,000 US dollars minus 77,000,000 US dollars equals 593,000,000 US dollars.
Bausch Health Companies Inc. (BHC) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!